Phosphodiesterase 10A inhibition attenuates sleep deprivation-induced deficits in long-term fear memory

Neurosci Lett. 2016 Dec 2:635:44-50. doi: 10.1016/j.neulet.2016.10.017. Epub 2016 Oct 12.

Abstract

Sleep, particularly rapid eye movement (REM) sleep, is implicated in the consolidation of emotional memories. In the present study, we investigated the protective effects of a phosphodiesterase 10A (PDE10A) inhibitor MP-10 on deficits in long-term fear memory induced by REM sleep deprivation (REM-SD). REM-SD caused deficits in long-term fear memory, however, MP-10 administration ameliorated the deleterious effects of REM-SD on long term fear memory. Brain-derived neurotropic factor (BDNF) and phosphorylated cAMP response element-binding protein (pCREB) were altered in specific brain regions associated with learning and memory in REM-SD rats. Accordingly, REM-SD caused a significant decrease of pCREB in hippocampus and striatum and a significant decrease of BDNF in the hippocampus, striatum and amygdala, however, MP-10 reversed the effects of REM-SD in a dose-dependent manner. Our findings suggest that REM-SD disrupts the consolidation of long-term fear memory and that administration of MP-10 protects the REM-SD-induced deficits in fear memory, which may be due to the MP-10-induced expression of BDNF in the hippocampus, striatum and amygdala, and phosphorylation of CREB in the hippocampus and striatum.

Keywords: Fear memory; Phosphodiesterase-10; REM sleep deprivation.

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Fear / drug effects*
  • Male
  • Memory Disorders / drug therapy*
  • Memory Disorders / etiology
  • Memory Disorders / psychology
  • Memory, Long-Term / drug effects*
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Phosphoric Diester Hydrolases / metabolism*
  • Phosphorylation
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use*
  • Quinolines / pharmacology
  • Quinolines / therapeutic use*
  • Rats, Sprague-Dawley
  • Reflex, Startle / drug effects
  • Sleep Deprivation / complications
  • Sleep Deprivation / psychology*
  • Sleep, REM*

Substances

  • 2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline
  • Brain-Derived Neurotrophic Factor
  • Cyclic AMP Response Element-Binding Protein
  • Phosphodiesterase Inhibitors
  • Pyrazoles
  • Quinolines
  • PDE10A protein, human
  • Phosphoric Diester Hydrolases